Articles by Tim Burroughs
AVCJ Awards: AVCJ Special Achievement: First Eastern's Victor Chu
Victor Chu’s First Eastern Investment Group was among the first private equity firms to enter China. It has since carved a new niche based on Chinese outbound investment
AVCJ Awards: PE Professionals of the Year: KKR's David Liu & Julian Wolhardt
David Liu and Julian Wolhardt lead KKR’s Greater China private equity team, with Liu also serving as co-head of Asia private equity. They look back on a busy 12 months
AVCJ Awards: Exit of the Year - IPO: Alibaba Group
Alibaba Group’s IPO validated Silver Lake’s faith in the business. Ken Hao, a managing partner at the PE firm, expects the company to go from strength to strength, both in and outside China
AVCJ Awards: Deal of the Year - Large Cap: Nanfu Battery
CDH Investments’ acquisition of Nanfu Battery is a rare carve-out from a multinational in China, and an even rarer example of a PE firm returning to back a former portfolio company
AVCJ Awards: Fundraising of the Year - Large Cap: CVC Capital Partners
Buoyed by strong returns out of Southeast Asia and pipeline of China control deals, CVC Capital Partners defied early expectations by closing Fund IV at the hard cap
AVCJ Awards: Fundraising of the Year - Mid Cap: Quadrant Private Equity
Quadrant Private Equity raised its seventh fund in record time, resisting pressure from LPs to enlarge the corpus. The Australian GP remains resolutely middle market
AVCJ Awards: Fundraising of the Year - Venture Capital: Qiming Venture Partners
Qiming Venture Partners closed its latest fund at $500 million this year. It wants a bigger slice of a growing Chinese internet market – but so does everyone else
AVCJ Awards: Operational Value Add & Exit of the Year - Large Cap: Oriental Brewery
Affinity Equity Partners and KKR made Oriental Brewery the market leader in Korea’s beer industry, then exited via Asia’s largest-ever trade sale. For this and other activities, Affinity was also named Firm of the Year
Fidelity backs China-based antibody specialist
Two Fidelity funds have participated in a Series A round of funding worth $8 million for Adagene, a China-based life sciences company that specializes in smart antibody technology.
SoftBank hitches a ride with GrabTaxi
Six months ago, Southeast Asia-focused mobile taxi-booking platform GrabTaxi was adjusting to the fact that its resources had ballooned by $15 million, following a Series B round provided by GGV Capital and Qunar. On this basis, the past six weeks have...
The trust factor: Repeat buying in Asian PE
Navis Capital Partners completed a management buyout of Dome Coffees Australia in 2003. The business grew and Navis prospered, securing a 3.5x return on exiting the asset via another management buyout five years later. Fast forward to September 2014 and...
I Squared Capital to buy India toll road from Malaysia's IJM
I Squared Capital, a PE firm set up by former executives of Morgan Stanley’s infrastructure investment unit, has agreed to buy a toll road in northwestern India from Malaysia-based IJM Corp.
Carlyle buys into India's Newgen for a second time
The Carlyle Group has acquired a 54.85% stake in India-based publishing and technical services provider Newgen KnowledgeWorks for $32.8 million via a secondary transaction. This is the second time it has invested in the company.
EQT sells Chinese bakery chain to Swire Foods
EQT has sold its 65% stake in Chongqing New Qinyuan Bakery, a retail bakery chain based in southwest China, to Swire Foods, a subsidiary of Swire Pacific.
Italy’s Bonomi raises offer for Fosun target Club Med
Andrea Bonomi has raised the stakes in the battle for Club Méditerranée (Club Med), increasing his offer for the vacation resort operator just days after a consortium led by China’s Fosun International submitted an improved bid.
China's Xiaomi, Kingsoft back IP investment fund
Chinese mobile phone maker Xiaomi and software developer Kingsoft will participate as LPs in a RMB200 million ($32.5 million) fund that will make investments related to intellectual property.
Australia's Crescent Capital closes Fund V at $565m
Crescent Capital Partners has reached a final close on its fifth Australia and New Zealand-focused fund at the hard cap of A$675 million ($565 million) after only 10 weeks in the market.
Quadrant-backed Estia drops on Australia trading debut
Estia Health, an Australian aged care provider backed by Quadrant Private Equity, saw its stock open at a 13% discount to the IPO price on the first day of trading in Sydney.
PEP, Bain offer $731m for Australia’s Bradken
Pacific Equity Partners (PEP) and Bain Capital have made an offer for mining industry supplier Bradken that values the Australia-listed company at approximately A$872 million ($731 million).
KKR backs Australian agribusiness specialist
KKR has committed at least $100 million to Sundrop Farms Holdings, an Australian agribusiness company that has developed technology for growing crops in arid climates.
Capital Today, DST, Hillhouse raise $619m through JD.com share sale
Capital Today, DST Advisors and Hillhouse Capital Management have raised $618.9 million by selling a portion of their shares in JD.com, the Chinese online retailer that went public earlier this year.
TPG to exit stake in Japanese toy maker
TPG will exit Japanese toymaker Tomy through a buyback by the company. Tomy has agreed to acquire the private equity firm’s entire equity holding and also redeem its convertible bond holdings.
Chinese investors join $40m round for Misfit Wearables
GGV Capital, Shunwei Venture Partners, smart phone maker Xiaomi and online retailer JD.com have participated in a $40 million Series C round of funding for Misfit Wearables, which manufactures wearable devices that track health and fitness.
Fenox VC launches $200m Bangladesh fund
Silicon Valley venture capital firm Fenox VC is launching a $200 million fund that will focus on investments in Bangladesh’s technology, internet and media sectors.